Prestige Consumer Healthcare Inc. (PBH) earnings
PBH earnings moved a median of +0.44% by the close. Quarterly and annual PBH reports and results, each read against the price at its own news timestamp. Back to the PBH overview →
29 measured PBH earnings events.
Where these PBH earnings landedvs 29 measured PBH earnings reactions
| Middle 50% of PBH earnings reactions | -1.57% to +2.28% |
|---|---|
| Median reaction (to close) | +0.44% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 PBH earnings events with a measured close landed between -1.57% and +2.28%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results | Press release | -0.62% | -0.62% | |
| Form 10-Q Prestige Consumer Health For: Jun 30 | SEC filing · Form 10-Q | +0.31% | -1.75% | |
| Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results | Press release | +0.31% | -1.75% | |
| Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date | Press release | -0.64% | -0.41% | |
| Form 10-K Prestige Consumer Health For: Mar 31 | SEC filing · Form 10-K | +3.03% | +0.49% | |
| Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results | Press release | -1.47% | +1.02% | |
| Form 10-Q Prestige Consumer Health For: Dec 31 | SEC filing · Form 10-Q | +2.06% | +2.28% | |
| Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference | Press release | -0.29% | +0.94% | |
| Form 10-Q Prestige Consumer Health For: Sep 30 | SEC filing · Form 10-Q | -0.43% | +0.44% | |
| Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results | Press release | +0.21% | -0.21% | |
| Form 10-Q Prestige Consumer Health For: Jun 30 | SEC filing · Form 10-Q | -1.68% | -4.78% | |
| Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results | Press release | -1.68% | -4.78% | |
| Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results | Press release | +0.00% | -1.52% | |
| Form 10-K Prestige Consumer Health For: Mar 31 | SEC filing · Form 10-K | +0.00% | +1.37% | |
| Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | Press release | -0.32% | +3.84% | |
| UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | Press release | -0.32% | +3.84% | |
| Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results | Press release | -1.11% | +1.53% | |
| Form 10-Q Prestige Consumer Health For: Dec 31 | SEC filing · Form 10-Q | -4.86% | +4.61% | |
| Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook | Press release | -4.86% | +4.61% | |
| Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation | Press release | +0.45% | +0.80% | |
| Form 10-Q Prestige Consumer Health For: Sep 30 | SEC filing · Form 10-Q | -2.04% | +2.82% | |
| Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results | Press release | -0.25% | +0.15% | |
| Form 10-Q Prestige Consumer Health For: Jun 30 | SEC filing · Form 10-Q | -0.01% | -4.25% | |
| Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results | Press release | +0.00% | -1.72% | |
| Form 10-K Prestige Consumer Health For: Mar 31 | SEC filing · Form 10-K | +1.34% | +3.17% | |
| Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results | Press release | +0.00% | +0.19% | |
| Form 10-Q Prestige Consumer Health For: Dec 31 | SEC filing · Form 10-Q | -8.58% | +4.83% | |
| Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results | Press release | -0.28% | -1.57% | |
| Form 10-Q Prestige Consumer Health For: Sep 30 | SEC filing · Form 10-Q | +0.03% | -2.89% |
Keep exploring
More PBH: analyst actions → · SEC filings → · PBH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RenovaCare, Inc. (RCAR) | 286 | 0.00% | 41% |
| Cellectis S.A. - American Depositary Shares (CLLS) | 285 | -0.01% | 37% |
| Xencor, Inc. (XNCR) | 285 | +0.09% | 52% |
| NOVELION THERAPEUTICS INC COMMON SHARES (NVLN) | 283 | 0.00% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.